An Artificial Intelligence System for Multimodal, Multi-class Diagnosis of Pancreatic Cystic Lesions Based on Endoscopic Ultrasonography

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorQilu Hospital of Shandong University

About this trial

The aim of this study is to develop and validate an artificial intelligence system named iEUS-PCL (intelligent endoscopic ultrasound system-pancreatic cystic lesions) for detecting and multimodal, multi-class diagnosing pancreatic cystic lesions (PCL) during endoscopic ultrasound (EUS) examination.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients aged ≥18 years scheduled for EUS with suspected pancreatic cystic lesions based on clinical symptoms, medical history, laboratory tests or radiological examinations, and who agree to participate in the research and voluntarily sign the informed consent.

Patients with no prior history of treatment for pancreatic lesions.

Disqualifiers

Patients with absolute contraindications to EUS examination.

Pregnancy or lactating.

Uncorrectable coagulopathy (PTT>50 seconds or INR>1.5) and/or uncorrectable thrombocytopenia(platelet count<50×109/L).

Upper gastrointestinal obstruction.

Trial population

Adult patients with suspected pancreatic cystic lesions undergoing EUS.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • iEUS-PCL(intelligent endoscopic ultrasound system- pancreatic cystic lesion)

    Device

    The iEUS-PCL will automatically detect pancreatic cystic lesions and integrate the patients' EUS images, EUS features, clinical data and radiological imaging features to perform three classification tasks: 1. binary classification: benign/malignant lesions; 2. binary classification: mucinous/non-mucinous lesions; 3. four-category classification: intraductal papillary mucinous neoplasm/ mucinous cystic neoplasm/ serous cyst neoplasm/ pancreatic cyst.

Treatment groups

176 Participants
are divided into 1 treatment group
Group A: Patients undergoing EUS1 intervention

Trial outcomes

Primary outcomes

1

The accuracy of iEUS-PCL for pancreatic cystic lesions

The primary outcome of the study is to evaluate the accuracy of the iEUS-PCL in identifying the pancreatic cystic lesions (benign/malignant; mucinous/non-mucinous; 4-category).

Time frame
During procedure
2

The sensitivity of iEUS-PCL for pancreatic cystic lesions

The primary outcome of the study is to evaluate the sensitivity of the iEUS-PCL in identifying the pancreatic cystic lesions (benign/malignant; mucinous/non-mucinous; 4-category).

Time frame
During procedure
3

The specificicy of iEUS-PCL for pancreatic cystic lesions

The primary outcome of the study is to evaluate the specificity of the iEUS-PCL in identifying the pancreatic cystic lesions (benign/malignant; mucinous/non-mucinous; 4-category).

Time frame
During procedure
4

The postive predictive value of iEUS-PCL for pancreatic cystic lesions

The primary outcome of the study is to evaluate the postive predictive value of the iEUS-PCL in identifying the pancreatic cystic lesions (benign/malignant; mucinous/non-mucinous; 4-category).

Time frame
During procedure

Secondary outcomes

1

Comparison of the accuracy between iEUS-PCL and endosonographers

The secondary outcome of the study is to comparing the accuracy between iEUS-PCL and different-level endosonographers in identifying the pancreatic cystic lesions (benign/malignant; mucinous/non-mucinous; 4-category).

Time frame
During procedure
2

Comparison of the sensitivity between iEUS-PCL and endosonographers

The secondary outcome of the study is to comparing the sensitivity between iEUS-PCL and different-level endosonographers in identifying in identifying the pancreatic cystic lesions (benign/malignant; mucinous/non-mucinous; 4-category).

Time frame
During procedure
3

Comparison of the specificity between iEUS-PCL and endosonographers

The secondary outcome of the study is to comparing the specificity between iEUS-PCL and different-level endosonographers in identifying in identifying the pancreatic cystic lesions (benign/malignant; mucinous/non-mucinous; 4-category).

Time frame
During procedure
4

Comparison of the postive predictive value between iEUS-PCL and endosonographers

The secondary outcome of the study is to comparing the postive predictive value between iEUS-PCL and different level endosonographers in identifying in identifying the pancreatic cystic lesions (benign/malignant; mucinous/non-mucinous; 4-category).

Time frame
During procedure

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Qilu Hospital of Shandong University

Lead sponsor

Liaocheng People's Hospital

Collaborator

Taian City Central Hospital

Collaborator

Qilu Hospital of Shandong University (Qingdao)

Collaborator

Binzhou People's Hospital

Collaborator

Shandong Provincial Hospital

Collaborator

The Affiliated Hospital of Qingdao University

Collaborator

Qianfoshan Hospital

Collaborator

Shengli Oilfield Hospital

Collaborator

Binzhou Medical University

Collaborator